Abstract:Objective: To investigate the antitumor effect of endostatin combined with tumor antigen-pulsed dendritic cell（DC）-T cell therapy on lung cancer.Methods: Transplanted Lewis lung cancer（LLC） models of C57BL/6 mice were established by subcutaneous injection of LLC cells in left extremity axillary. Tumor antigen-pulsed DC-T cells from spleen cells and bone of mice were cultured in vitro. Tumor-bearing mice were randomly divided into three groups, including DCT+endostatin group, DC-T group, and phosphate-buffered saline（PBS） control group. Microvessel density（MVD） of tumor tissue in tumor-bearing mice was determined by immunohistochemistry（IHC）. The expressions of vascular endothelial growth factor（VEGF） and hypoxia-inducible factor-1α（HIF-1α） were determined by Western blotting and IHC staining. The proportions of CD8+ T cells, mature dendritic cells（m DC）, tumor-associated macrophages [TAM（M1/M2）], and myeloid-derived suppressor cells（MDSC） in suspended cells of tumor tissue were determined by flow cytometry. The expressions of interleukin（IL）-6, IL-10, IL-17, transforming growth factor-β（TGF-β） and interferon-γ（IFN-γ） in suspended cells of tumor tissue were detected by enzyme-linked immune sorbent assay（ELISA）.Results: DC-T cells combined with endostatin remarkably suppressed tumor growth. MVD of mice in DCT+endostatin group was significantly lower than that of the control group and DC-T monotherapy group. The expressions of VEGF, IL-6 and IL-17 in tumors were markedly decreased, but IFN-γ and HIF-1α increased after treating with DC-T cells combined with endostatin, compared to control group and DC-T group. In the DCT+endostatin group, the proportions of MDSC and TAM（M2 type） were significantly decreased, m DC and TAM（M1 type） were up-regulated, and CD8+ T cells were recruited to infiltrate tumors, in contrast to PBS control and DC-T monotherapy. DC-T cells combined with endostatin potently reduced the expressions of IL-6, IL-10, TGF-β and IL-17 in tumor tissue, and enhanced the expression of IFN-γ.Conclusions: The study indicated the synergic antitumor effects between endostatin and tumor antigen-pulsed DC-T cells, which may be a prospective therapy strategy to achieve potent antitumor effects on lung cancer.

Inhibitory Effects of the Nanoscale Lysate Derived from Xenogenic Dental Pulp Stem Cells in Lung Cancer Models

Inhibitory potential of nanoscale dental pulp stem cell lysate in lung cancer with risk of lymph node metastasis

Inhibitory Effect and Molecular Mechanism of Mesenchymal Stem Cells on NSCLC Cells

Drug-Free Mesoporous Silica Nanoparticles Enable Suppression of Cancer Metastasis and Confer Survival Advantages to Mice with Tumor Xenografts

Inhibition of Lung Cancer Cell Proliferation Mediated by Human Mesenchymal Stem Cells

Elevated Expression of Podoplanin and Its Clinicopathological, Prognostic, and Therapeutic Values in Squamous Non-Small Cell Lung Cancer

[Astragalus polysaccharide combined with cisplatin inhibits growth of recurrent tumor and down-regulats the expression of CD44, CD62P and osteopontin in tumor tissues in mice bearing Lewis lung cancer]

Suppression of Lung Cancer in Murine Model: Treated by Combination of Recombinant Human Endostsatin Adenovirus with Low-Dose Cisplatin

Experimental research on docetaxel loaded PEG-albumin nanoparticles to the situ carcinoma model of non-small cell lung cancer

Effects of Human Umbilical Cord-derived Mesenchymal Stem Cells Extracts on Human Lung Cancer Cells A549

Xiaoliu Pingyi Pecipe Inhibits Lung Pre-Metastatic Niche Formation and Prevents Myeloid-Derived Suppressor Cells Recruitment

Efficient Lung Cancer-Targeted Drug Delivery Via a Nanoparticle/msc System

Endostatin Enhances Antitumor Effect of Tumor Antigen-Pulsed Dendritic Cell Therapy in Mouse Xenograft Model of Lung Carcinoma

Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion

Dendrobine Suppresses Tumor Growth by Regulating the PD-1/PD-L1 Checkpoint Pathway in Lung Cancer

In vitro induction of anti‐lung cancer immune response by the A549 lung cancer stem cell lysate‐sensitized dendritic cell vaccine

Enhanced Anti-Metastatic Therapy with Down-Regulation of Heparinase Expression by ROS-responsive Micellar Nanoparticles.

Inhibitive Effect of LAK Cells Induced by Dendritic Cells on Implanted Lung Cancer in Nude Mice

SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/mTOR Signaling Pathways

Active Targeting Docetaxel-Pla Nanoparticles Eradicate Circulating Lung Cancer Stem-Like Cells and Inhibit Liver Metastasis.

SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway